CELG.RT
Bristol-Myers Squibb Company Contingent Value Rights
CELG.RT
CELG.RT
hedge funds and large institutions have invested in Bristol-Myers Squibb Company Contingent Value Rights in 2013 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$3.44M
Puts
–
Net Calls
+$3.44M
Net Calls Change
+$3.44M
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
JPMorgan Chase & Co
New York
| – | – | – | – |
|